Weixia Li

Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy

Ying Cheng, Jianxing He, R. Guo, 2020, Clinical Cancer Research.

Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.

Ying Su, Liwei Zhao, Xueling Wang, 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Efficacy and safety of camrelizumab plus apatinib as second-line treatment for advanced squamous non-small cell lung cancer

R. Guo, Jun Zhao, S. Ren, 2021, Annals of translational medicine.

Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration

Jianxing He, R. Guo, Jun Zhao, 2021, Translational lung cancer research.